相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine
Allen L. Malisa et al.
MALARIA JOURNAL (2010)
Chlorproguanil-Dapsone-Artesunate versus Artemether-Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
Zul Premji et al.
PLOS ONE (2009)
Mutational reversions during adaptive protein evolution
Mark A. DePristo et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Darwinian evolution can follow only very few mutational paths to fitter proteins
DM Weinreich et al.
SCIENCE (2006)
The past, present and future of antifolates in the treatment of Plasmodium falciparum infection
Alexis Nzila
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Mechanisms of resistance of malaria parasites to antifolates
A Gregson et al.
PHARMACOLOGICAL REVIEWS (2005)
DNA and RNA synthesis: Antifolates
IM Kompis et al.
CHEMICAL REVIEWS (2005)
Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil
SY Hunt et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2005)
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial
A Alloueche et al.
LANCET (2004)
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial
J Sulo et al.
LANCET (2002)
Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum
N Nirmalan et al.
MOLECULAR MICROBIOLOGY (2002)
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
MD Hastings et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria
JG Kublin et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli
S Chusacultanachai et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum:: what next?
CH Sibley et al.
TRENDS IN PARASITOLOGY (2001)
Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210
EG Hankins et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Mutagenesis of dihydrofolate reductase from Plasmodium falciparum:: analysis in Saccharomyces cerevisae of triple mutant alleles resistant to pyrimethamine or WR99210
JT Ferlan et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
AM Nzila et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase:: Structural basis of antifolate resistance
G Rastelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)